KOSPI · Healthcare · ₩118B
₩8,600+4.37%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.7% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“판매 회복은 분명해졌고 이제 실속 있는 성장인지 확인할 때예요.”
In the company's words · 2026 2분기 filing